Information Provided By: 
Fly News Breaks for December 28, 2016
CAPN
Dec 28, 2016 | 07:39 EDT
Maxim analyst Jason Kolbert said Capnia's merger with privately-held Essentialis creates a new company that will focus on diazoxide choline controlled release tablet, a treatment of patients with Prader-Willi syndrome. While he needs additional time to evaluate the probabilities of success in developing this drug for PWS, a rare complex genetic neurobehavioral/metabolic disease, and waits for detail on what will happen with its CoSense diagnostics business and Serenz, he keeps a Hold rating on Capnia shares.
News For CAPN From the Last 2 Days
There are no results for your query CAPN
